These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 16678216)
21. Escitalopram : a review of its use in the management of major depressive and anxiety disorders. Waugh J; Goa KL CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392 [TBL] [Abstract][Full Text] [Related]
22. Serotonergic mechanisms in the basolateral amygdala differentially regulate the conditioned and unconditioned fear organized in the periaqueductal gray. Martinez RC; Ribeiro de Oliveira A; Brandão ML Eur Neuropsychopharmacol; 2007 Nov; 17(11):717-24. PubMed ID: 17398077 [TBL] [Abstract][Full Text] [Related]
23. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter]. Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789 [TBL] [Abstract][Full Text] [Related]
24. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Zanoveli JM; Nogueira RL; Zangrossi H Neuropharmacology; 2007 Mar; 52(4):1188-95. PubMed ID: 17313964 [TBL] [Abstract][Full Text] [Related]
25. Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray. Batistela MF; Vilela-Costa HH; Frias AT; Hernandes PM; Lovick TA; Zangrossi H J Psychopharmacol; 2021 Dec; 35(12):1523-1535. PubMed ID: 34872406 [TBL] [Abstract][Full Text] [Related]
26. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. Schreiber S; Pick CG Eur Neuropsychopharmacol; 2006 Aug; 16(6):464-8. PubMed ID: 16413173 [TBL] [Abstract][Full Text] [Related]
27. Serotonin in the dorsal periaqueductal gray inhibits panic-like defensive behaviors in rats exposed to acute hypoxia. Spiacci A; Sergio Tde O; da Silva GS; Glass ML; Schenberg LC; Garcia-Cairasco N; Zangrossi H Neuroscience; 2015 Oct; 307():191-8. PubMed ID: 26319117 [TBL] [Abstract][Full Text] [Related]
28. Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray. Lim LW; Blokland A; Tan S; Vlamings R; Sesia T; Aziz-Mohammadi M; Visser-Vandewalle V; Steinbusch HW; Schruers K; Temel Y Exp Neurol; 2010 Dec; 226(2):293-300. PubMed ID: 20837005 [TBL] [Abstract][Full Text] [Related]
31. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. Zanoveli JM; Nogueira RL; Zangrossi H Behav Pharmacol; 2005 Nov; 16(7):543-52. PubMed ID: 16170231 [TBL] [Abstract][Full Text] [Related]
32. alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice. Massé F; Hascoët M; Bourin M Behav Brain Res; 2005 Oct; 164(1):17-28. PubMed ID: 16081166 [TBL] [Abstract][Full Text] [Related]
34. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model. Sánchez C; Gruca P; Papp M Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259 [TBL] [Abstract][Full Text] [Related]
35. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Jenck F; Moreau JL; Martin JR Psychiatry Res; 1995 Jul; 57(2):181-91. PubMed ID: 7480384 [TBL] [Abstract][Full Text] [Related]
36. Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze. Beijamini V; Andreatini R Pharmacol Res; 2003 Aug; 48(2):199-207. PubMed ID: 12798673 [TBL] [Abstract][Full Text] [Related]
37. Panicolytic-like effect of BDNF in the rat dorsal periaqueductal grey matter: the role of 5-HT and GABA. Casarotto PC; de Bortoli VC; Corrêa FM; Resstel LB; Zangrossi H Int J Neuropsychopharmacol; 2010 Jun; 13(5):573-82. PubMed ID: 20047714 [TBL] [Abstract][Full Text] [Related]
38. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457 [TBL] [Abstract][Full Text] [Related]